EP3838271
MEÐFERÐ VIÐ AUKNU MAGNI SÝRUFRUMNA OG/EÐA BASAFRUMNA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.7.2014EP published:
3.9.2025EP application number:
21155067.8
EP translation filed:
29.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
10.7.2034Expiry date:
10.7.2026
Title in English:
TREATING ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILSLanguage of the patent:
English
Timeline
Today
11.7.2014EP application
3.9.2025EP Publication
29.9.2025Translation submitted
15.10.2025Registration published
10.7.2026Expires
Owner
Name:
Areteia Therapeutics, Inc.Address:
101 Glen Lennox Drive, Suite 300, Chapel Hill, NC 27517, US
Inventor
Name:
Bozik, Michael E.Address:
Pittsburgh, PA 15090, US
Name:
Hebrank, GregoryAddress:
Greenburg, PA 15601, US
Name:
Petzinger, Jr., ThomasAddress:
Pittsburgh, PA 15217, US
Name:
Dworetzky, StevenAddress:
Jefferson Hills, PA 15025, US
Name:
Farwell, WildonAddress:
Wayland, MA 01778, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361845944 PDate:
12.7.2013Country:
US
Number:
201361859158 PDate:
26.7.2013Country:
US
Number:
201361865118 PDate:
12.8.2013Country:
US
Number:
201313966229Date:
13.8.2013Country:
US
Number:
PCT/US2013/054804Date:
13.8.2013Country:
WO
Number:
201461987117 PDate:
1.5.2014Country:
US
Classification
Categories:
A61K 31/428, A61P 43/00, A61P 1/00, A61P 11/00, A61P 11/02, A61P 11/06, A61P 17/00, A61P 1/02, A61P 1/04, A61P 1/16, A61P 7/00, A61P 9/00, A61P 13/08, A61P 21/02, A61P 31/10, A61P 33/06, A61P 33/10, A61P 35/02, A61P 37/08